Judith S. Currier, M.D., M.Sc.

Dr. Currier's Articles on Opportunistic Infections

• Opportunistic Infections in the Protease Era (February 21, 1998)
  Adapted from a presentation for the International AIDS Society -- USA CME Program
  By Judith S. Currier, M.D., M.Sc.
• Update on Fungal Infections (February 1998)
  From the 5th Conference on Retroviruses and Opportunistic Infections
  By Judith S. Currier, M.D., M.Sc.
• New Insights into HIV-Related Complications (March 1997)
  Highlights of the 5th Retrovirus Conference
  By Judith S. Currier, M.D., M.Sc.
  and Diane V. Havlir, M.D.
• Bacterial Infections in HIV Disease (1995/1996)
  By Judith S. Currier, M.D., M.Sc.
  and Judith Feinberg, M.D.
  
  • Introduction
  • Pathogenesis
  • Epidemiology
  • Specific Syndromes
    Bacterial Pneumonia
    Bacteremia
    Endocarditis
    Bacillary Angiomatosis
    Sinusitis
    
  • Prevention
    Pneumococcal Vaccination
    Antibiotic Prophylaxis
    Intravenous Immunoglobulin
    
  • Conclusions
  • References

Dr. Currier is an Associate Professor of Medicine at the University of California, Los Angeles, School of Medicine and the Associate Director of the UCLA Center for Clinical AIDS Research and Education.

Dr. Currier is involved in clinical trials evaluating new therapies for HIV infection. Her research interests include antiretroviral therapy, HIV in women, and opportunistic infections.

Dr. Currier is a member of the NIAID AIDS Clinical Trials Group Complications of HIV Research Agenda Committee and is the Chair of the Mycobacterial/Bacterial Pathogen Study Group.

Support for Dr. Currier's research is provided by Merck & Co., Inc., Agouron Pharmaceuticals, Amgen, Pfizer Inc. and Abbott Laboratories.

Dr. Currier's participation in the Opportunistic Infections and Treatment Forums at The Body was sponsored in part by unrestricted educational grants from Pfizer Inc. and Merck & Co., Inc. respectively.